John T. Maxwell
2019
In 2019, John T. Maxwell earned a total compensation of $1.1M as Chief Financial Officer at Aquestive Therapeutics, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,490 |
|---|---|
| Option Awards | $516,975 |
| Salary | $391,154 |
| Other | $26,504 |
| Total | $1,054,123 |
Maxwell received $517K in option awards, accounting for 49% of the total pay in 2019.
Maxwell also received $119.5K in non-equity incentive plan, $391.2K in salary and $26.5K in other compensation.
Rankings
In 2019, John T. Maxwell's compensation ranked 9,051st out of 13,971 executives tracked by ExecPay. In other words, Maxwell earned more than 35.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,051 out of 13,971 | 35th |
Division Manufacturing | 3,627 out of 5,692 | 36th |
Major group Chemicals And Allied Products | 1,368 out of 2,189 | 38th |
Industry group Drugs | 1,166 out of 1,875 | 38th |
Industry Pharmaceutical Preparations | 861 out of 1,387 | 38th |
Source: SEC filing on April 29, 2020.
Maxwell's colleagues
We found two more compensation records of executives who worked with John T. Maxwell at Aquestive Therapeutics in 2019.